Bookmark

Add to MyYahoo RSS

Human Genome Sciences News

News on Human Genome Sciences (Ticker: HGSI) continually updated from thousands of sources around the net.

9 hrs ago | Freshnews

Horizon Pharma Announces the Appointment of H. Thomas Watkins to Its Board of Directors

Additionally, Jean-Francois Formela, M.D. has resigned from the Horizon board of directors.

Comment?

Related Topix: Biotech, Human Genome Sciences, Medicine, Healthcare Industry

Wed Apr 16, 2014

BioSpace

Scheer Partners, Inc. Hired By To Lease 9410 Key West Avenue In Rockville

Scheer Partners, the leading provider of fully integrated commercial real estate services for the health science industry in the Washington and Baltimore metropolitan areas, announced today that Chevy Chase-based DANAC, LLC has engaged the Rockville-based company to market a full building containing 48,270 square feet of contiguous laboratory, ... (more)

Comment?

Related Topix: Rockville, MD, Chevy Chase, MD, Biotech, Medicine, Healthcare Industry

Mon Mar 31, 2014

Business Journal

Bad news for GlaxoSmithKline's darapladib, a drug key to Human Genome Sciences buyout

GlaxoSmithKline this weekend illustrated disappointing results of a late-stage trial for heart drug darapladib, one of the three major assets the British pharma company scooped up in its $3 billion acquisition of Rockville's Human Genome Sciences two years ago.

Comment?

Related Topix: Biotech, Human Genome Sciences, Medicine, GlaxoSmithKline, Healthcare Industry

Sun Mar 30, 2014

Reuters

Study shows Glaxo heart drug which failed trial has potential benefit

An experimental heart drug being developed by GlaxoSmithKline, which failed the main goal of a Phase III study of patients with chronic but well-treated heart disease, showed signs of potential benefit, the trial's co-leader said Sunday.

Comment?

Related Topix: Biotech, Heart Disease, Health, Heart Attack, Medicine, Healthcare Industry, Stroke

Thu Mar 13, 2014

Freshnews

WellDoc Names Biotech Veteran as President

WellDoc , developers of the first FDA-cleared, mobile prescription therapy, BlueStar TM, announced today that Kevin P. McRaith has joined the Company as President.

Comment?

Related Topix: Marketing, Biotech, Human Genome Sciences, Healthcare Industry, University of Iowa, Iowa

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••
•••